Gonzalez Martin A.
Known title: EVP, Global Supply ChainCIK: 0001928623
Associated companies
Transaction History
| NATR | ▲ Buy | Option Exercise | 2,885 | $0 | 11/4/2025 | View on chart |
| NATR | ▼ Sell | Tax Withholding | 833 | $11K | 11/4/2025 | View on chart |
| NATR | ▲ Buy | Option Exercise | 2,910 | $0 | 11/4/2025 | View on chart |
| NATR | ▼ Sell | Tax Withholding | 840 | $12K | 11/4/2025 | View on chart |
| NATR | ▼ Sell | Tax Withholding | 3,781 | $56K | 7/21/2025 | View on chart |
| NATR | ▼ Sell | Tax Withholding | 1,290 | $19K | 3/11/2025 | View on chart |
| NATR | ▲ Buy | Grant | 13,758 | $203K | 3/10/2025 | View on chart |
| NATR | ▼ Sell | Tax Withholding | 3,787 | $59K | 7/21/2024 | View on chart |
| NATR | ▼ Sell | Tax Withholding | 1,997 | $39K | 4/20/2024 | View on chart |
| NATR | ▲ Buy | Grant | 11,311 | $0 | 3/11/2024 | View on chart |
| NATR | ▼ Sell | Tax Withholding | 3,654 | $50K | 7/21/2023 | View on chart |
| NATR | ▲ Buy | Grant | 17,458 | $0 | 4/20/2023 | View on chart |
| NATR | ▲ Buy | Grant | 37,500 | $0 | 7/21/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
Nature's Sunshine Q2 Earnings Reviewed Against Peers
A recent analysis compared Nature's Sunshine's second-quarter results with other personal care companies. This review helps investors understand how the stock performed relative to its sector during that period. The company currently trades with a trailing P/E ratio of 13.3, while analysts maintain an average price target of $30.50.
Nature's Sunshine Q2 Earnings Reviewed Against Peers. A recent analysis compared Nature's Sunshine's second-quarter results with other personal care companies. This review helps investors understand how the stock performed relative to its sector during that period. The company currently trades with a trailing P/E ratio of 13.3, while analysts maintain an average price target of $30.50.